PLEASANTON, Calif.--(BUSINESS WIRE)--
ZELTIQ Aesthetics, Inc. (ZLTQ) the medical technology company that developed CoolSculpting, a non-surgical, clinically proven procedure designed to selectively eliminate diet and exercise resistant fat using a patented cooling technology today announced a new agreement with CareCredit, a leading healthcare credit card, to provide payment options to patients.
Launched nationwide, the new agreement will provide ZELTIQs network of more than 400 physicians the opportunity to offer their patients special financing. Even if patients have the funds available, CareCredit provides payment options for patients to build cosmetic procedures such as CoolSculpting into their monthly budget.
Although CoolSculpting is thought to be attractively priced by consumers we speak with, this program provides payment options that patients have requested, said Mark Foley, Interim President and Chief Executive Officer of ZELTIQ. Thanks to this strong relationship with CareCredit, CoolSculpting will further expand the aesthetic category by providing those considering treatment with more choices on how to budget and benefit from our differentiated procedure.
CareCredit is a healthcare credit card that provides patients with a revolving line of credit, specifically for elective procedures like CoolSculpting, said Tony Seymour, Senior Vice President, Sales, CareCredit. For over 25 years, we have provided payment options that patients value and enable them to get the care they want and need for themselves and their family members. We look forward to working with CoolSculpting practices and their patients.
CareCredit is currently accepted by over 150,000 providers. Patients can apply for CareCredit in the CoolSculpting providers office, online at carecredit.com, or via their mobile devices with the SmartPhone enabled application app. Cardholders and providers consistently share feedback about CareCredits value and ease-of-use. Results from regular surveys* of more than 1,500 cardholders confirm: more than 96 percent of cardholders say they are highly satisfied with the program and that the service meets or exceeds their expectations; more than 95 percent of both cardholders and providers consistently rate it a fair to excellent value; and more than 86 percent indicate they would recommend to a friend.
About CoolSculpting
CoolSculpting is a non-surgical, clinically proven procedure designed to selectively reduce fat bulges in problem areas using a patented cooling technology. Physicians report a 95 percent patient satisfaction rate1. It is a procedure cleared by the FDA that gently cools unwanted fat cells in the body to induce a natural, controlled elimination of fat cells. It is designed to reduce fat bulges in treated areas of the body without harming surrounding tissue. CoolSculpting is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at http://www.coolsculpting.com.
About ZELTIQ
ZELTIQ Aesthetics, Inc. (ZLTQ) is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQs first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer within a treated fat bulge without requiring the patient to diet or exercise.
Read more from the original source:
CoolSculpting® More Accessible to Patients Through New Financing Agreement with CareCredit
